The scandal involving foreign pharmaceutical companies bribing Chinese physicians has widened. It was only a month ago that four executives from GlaxoSmithKline were detained by Chinese officials for pay-offs. French pharmaceutical maker Sanofi Pharmaceuticals is now being named as well. Seems the issue of Medical Ethics is rampant.
On August 8, 2013, writer Denise Roland for The Telegraph detailed the latest accusations of bribery in an article entitled: “Sanofi dragged into China bribery scandal with media report.”
Apparently, “An anonymous whistleblower,” came forward detailing payments made to physicians in 2007, “to 503 doctors across 79 hospitals in Shanghai, Beijing, Hangzhou and Guangzhou.” The amount of the bribery was about $290,000 in U.S. dollars. The whistleblower was fairly credible, and is believed to have once been a Sanofi executive.